File Download
There are no files associated with this item.
Supplementary
-
Citations:
- Appears in Collections:
Conference Paper: Incidence of deferasirox-associated renal tubular dysfunction in children and young adults with beta-thalassemia
Title | Incidence of deferasirox-associated renal tubular dysfunction in children and young adults with beta-thalassemia |
---|---|
Authors | |
Keywords | Pediatrics |
Issue Date | 2014 |
Publisher | Medcom Limited. The Journal's web site is located at http://www.hkjpaed.org/index.asp |
Citation | The 2014 Joint Annual Scientific Meeting of the Hong Kong Paediatric Society and Hong Kong Paediatric Nurses Association, Hong Kong, 15 June 2014. In Hong Kong Journal of Paediatrics, 2014, v. 19 n. 3, p. 193 How to Cite? |
Abstract | Renal tubular dysfunction has been reported in patients on deferasirox therapy but no systematic study has been performed. This study aimed to determine the cumulative incidence of renal tubular dysfunction and serum electrolyte imbalances among children and young adults with transfusion-dependent beta-thalassaemia on deferasirox and study their intermediate term outcomes. Mean age was 15.89 years (range: 2.6-24.10 years). Nine (50.0%) patients were on deferasirox, three (16.7%) were on deferoxamine, two (11.1%) were on deferiprone, and four (22.2%) were on combination deferiprone and deferoxamine. Twelve (66.7%) patients had renal tubular dysfunction, defined by elevated urine -2 microglobulin, of whom nine were on deferasirox. Eight patients (44.4%) had concomitant serum electrolyte imbalance, all of whom were on deferasirox. Compared to those on other chelation regimens, patients on deferasirox were more likely to develop renal tubular dysfunction (OR 35.3, p=0.009), hypokalaemia (OR 23.2, p=0.015), hypophosphataemia (OR 57.0, p=0.001), hypocalcaemia (OR 23.2, p=0.015), and Fanconi syndrome (OR 15.6, p=0.004). Cumulative incidence of renal tubular dysfunction was estimated to be 89% at 6 years of deferasirox therapy. These effects were reversible with suspension or dose reduction of deferasirox. Vigilant monitoring of renal tubular dysfunction and serum electrolyte is recommended in patients who receive deferasirox. |
Description | Oral Presentation This journal issue (pp. 192-206) entitled: Proceedings of Congress: Joint Annual Scientific Meeting 2014: The Hong Kong Paediatric Society and Hong Kong Paediatric Nurses Association 15 June, 2014 Open Access Journal |
Persistent Identifier | http://hdl.handle.net/10722/209588 |
ISSN | 2023 Impact Factor: 0.1 2023 SCImago Journal Rankings: 0.117 |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Dee, CMA | - |
dc.contributor.author | Cheuk, DKL | - |
dc.contributor.author | Ha, SY | - |
dc.contributor.author | Chiang, AKS | - |
dc.contributor.author | Chan, GCF | - |
dc.date.accessioned | 2015-05-05T02:13:20Z | - |
dc.date.available | 2015-05-05T02:13:20Z | - |
dc.date.issued | 2014 | - |
dc.identifier.citation | The 2014 Joint Annual Scientific Meeting of the Hong Kong Paediatric Society and Hong Kong Paediatric Nurses Association, Hong Kong, 15 June 2014. In Hong Kong Journal of Paediatrics, 2014, v. 19 n. 3, p. 193 | - |
dc.identifier.issn | 1013-9923 | - |
dc.identifier.uri | http://hdl.handle.net/10722/209588 | - |
dc.description | Oral Presentation | - |
dc.description | This journal issue (pp. 192-206) entitled: Proceedings of Congress: Joint Annual Scientific Meeting 2014: The Hong Kong Paediatric Society and Hong Kong Paediatric Nurses Association 15 June, 2014 | - |
dc.description | Open Access Journal | - |
dc.description.abstract | Renal tubular dysfunction has been reported in patients on deferasirox therapy but no systematic study has been performed. This study aimed to determine the cumulative incidence of renal tubular dysfunction and serum electrolyte imbalances among children and young adults with transfusion-dependent beta-thalassaemia on deferasirox and study their intermediate term outcomes. Mean age was 15.89 years (range: 2.6-24.10 years). Nine (50.0%) patients were on deferasirox, three (16.7%) were on deferoxamine, two (11.1%) were on deferiprone, and four (22.2%) were on combination deferiprone and deferoxamine. Twelve (66.7%) patients had renal tubular dysfunction, defined by elevated urine -2 microglobulin, of whom nine were on deferasirox. Eight patients (44.4%) had concomitant serum electrolyte imbalance, all of whom were on deferasirox. Compared to those on other chelation regimens, patients on deferasirox were more likely to develop renal tubular dysfunction (OR 35.3, p=0.009), hypokalaemia (OR 23.2, p=0.015), hypophosphataemia (OR 57.0, p=0.001), hypocalcaemia (OR 23.2, p=0.015), and Fanconi syndrome (OR 15.6, p=0.004). Cumulative incidence of renal tubular dysfunction was estimated to be 89% at 6 years of deferasirox therapy. These effects were reversible with suspension or dose reduction of deferasirox. Vigilant monitoring of renal tubular dysfunction and serum electrolyte is recommended in patients who receive deferasirox. | - |
dc.language | eng | - |
dc.publisher | Medcom Limited. The Journal's web site is located at http://www.hkjpaed.org/index.asp | - |
dc.relation.ispartof | Hong Kong Journal of Paediatrics (New series) | - |
dc.subject | Pediatrics | - |
dc.title | Incidence of deferasirox-associated renal tubular dysfunction in children and young adults with beta-thalassemia | - |
dc.type | Conference_Paper | - |
dc.identifier.email | Cheuk, DKL: cheukkld@hku.hk | - |
dc.identifier.email | Ha, SY: syha@hku.hk | - |
dc.identifier.email | Chiang, AKS: chiangak@hku.hk | - |
dc.identifier.email | Chan, GCF: gcfchan@hku.hk | - |
dc.identifier.authority | Chiang, AKS=rp00403 | - |
dc.identifier.authority | Chan, GCF=rp00431 | - |
dc.identifier.hkuros | 243057 | - |
dc.identifier.volume | 19 | - |
dc.identifier.issue | 3 | - |
dc.identifier.spage | 193 | - |
dc.identifier.epage | 193 | - |
dc.publisher.place | Hong Kong | - |
dc.identifier.issnl | 1013-9923 | - |